Added to YB: 2026-03-12
Pitch date: 2026-03-10
DSFIR.AS [neutral]
DSM-Firmenich AG
+5.4%
current return
Author Info
No bio for this author
Company Info
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
Market Cap
EUR 14.3B
Pitch Price
EUR 55.92
Price Target
N/A
Dividend
4.40%
EV/EBITDA
12.52
P/E
53.94
EV/Sales
1.98
Sector
Chemicals
Category
special_situation
KEDM Lite Vol. 5 - DSM-Firmenich AG
DSFIR.AS (update): Sold ANH unit for €2.2bn + €0.5bn earn-out as expected, but stock sold off post-announcement. Divestment shifts profile to higher growth, margins & pricing power. Cyclical headwinds pushed shares to lows. Investor Day Thu could be bullish catalyst; 2026 outlook pending amid weak sentiment & market turmoil.
Read full article (1 min)